Menu boczne

Treść strony

Ważniejsze publikacje

Wybrane prace z ostatnich 3 lat - opublikowane w czasopismach z listy filadelfijskiej o współczynniku oddziaływania (IF) powyżej 2.0 (w roku publikacji):

  1. Interleukin-18 promoter polymorphism in patients with atopic asthma. Pawlik A, Kaminski M, Kusnierczyk P, Kurzawski M, Dziedziejko V, Adamska M, Safranow K, Gawronska-Szklarz B. Tissue Antigens 2007; 70: 314–318.
  2. 677C>T and 1298A>C MTHFR polymorphisms affect methotrexate treatment outcome in rheumatoid arthritis. Kurzawski M, Pawlik A, Safranow K, Herczynska M, Drozdzik M. Pharmacogenomics 2007; 8:1551-1559.
  3. Association of PTPN22 single nucleotide polymorphism with rheumatoid arthritis but not with allergic asthma. Majorczyk E, Jasek M, Płoski R, Wagner M, Kosior A, Pawlik A, Obojski A, Luszczek W, Nowak I, Wiśniewski A, Kuśnierczyk P. Eur J Hum Genet 2007; 15:1043-8.
  4. Reduced folate carrier-1 80G>A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis. Drozdzik M, Rudas T, Pawlik A, Gornik W, Kurzawski M, Herczynska M. Pharmacogenomics J 2007 [Epub ahead of print].
  5. Low-density lipoprotein receptor-related protein-associated protein (LRPAP1) gene IVS5 insertion/deletion polymorphism is not a risk factor for gallstone disease in a Polish population. Juzyszyn Z, Kurzawski M, Modrzejewski A, Sulikowski T, Pawlik A, Czerny B, Droździk M. Dig Liv Dis 2007 [Epub ahead of print].
  6. Associations of killer cell immunoglobulin-like receptor genes with complications of rheumatoid arthritis. Majorczyk E, Pawlik A, Luszczek W, Nowak I, Wiśniewski A, Jasek M, Kuśnierczyk P. Genes Immun 2007; Epub ahead of print]
  7. Association of cytokine gene polymorphisms and the release of cytokines sfrom peripheral blood mononuclear cells treated with methotrexate and dexamethasone. Pawlik A, Baśkiewicz-Masiuk M, Machaliński B, Gawrońska-Szklarz B. Int Immunopharmacol 2006; 6: 351-357.
  8. Effect of CYP2C19*17 gene variant on Helicobacter pylori eradication in peptic ulcer patients. Kurzawski M, Gawronska-Szklarz B, Wrzesniewska J, Siuda A, Starzynska T, Drozdzik M. Eur J Clin Pharmacol 2006; 62:877-80.
  9. The effect of 3435C>T MDR1 gene polymorphism on rheumatoid arthritis treatment with disease-modifying antirheumatic drugs. Droździk M, Rudas T, Pawlik A, Kurzawski M, Czerny B, Górnik W, Herczyńska M. Eur J Clin Pharmacol 2006; 62: 933-937.
  10. Lidocaine pharmacokinetics In postmenopausal women on hormone therapy. Gawrońska-Szklarz B, Zarzycki M, Musial HD, Pudlo A, Łoniewski I, Droździk M. Menopause 2006; 13: 793-798.
  11. Interleukin-18 promoter polymorphism in patients with rheumatoid arthritis. Pawlik A, Kurzawski M, Czerny B, Gawronska-Szklarz B, Drozdzik M, Herczynska M. Tissue Antigens. 2006; 67: 415-8.
  12. Effect of trimetazidine on the nucleotide profile in rat kidney with ischemia-reperfusion injury. Domanski L, Sulikowski T, Safranow K, Pawlik A, Olszewska M, Chlubek D, Urasinska E, Ciechanowski K. Eur J Pharm Sci 2006; 27: 320-327
  13. Circulating adhesion molecules during kidney allograft reperfusion. Domanski L, Gryczman M, Pawlik A, Sulikowski M, Romanowski M, Ostrowski M, Myslak M, Rozanski J, Safranow K, Dutkiewicz G, Ciechanowski K. Transpl Immunol 2006; 16: 172-175.
  14. Distribution of CTLA-4 polymorphisms in allergic asthma. Jasek M, Luszczek W, Obojski A, Winiarska B, Halubek K, Nowak I, Manczak M, Wisniewski A, Pawlik A, Jonkisz A, Lebioda A, Majorczyk E, Dobosz T, Kusnierczyk P. Int Arch Allergy Immunol 2006; 141: 223-229.
  15. Involvement of C3435T and G2677T multidrug resistance gene polymorphisms in release of cytokines from peripheral blood mononuclear cells treated with methotrexate and dexamethasone. Pawlik A, Baskiewicz-Masiuk M, Machalinski B, Kurzawski M, Gawronska-Szklarz B. Eur J Pharmacol 2005; 528 : 27-36.
  16. Effect of CYP2C19 and MDR1 polymorphisms on cure rate in patients with acid-related disorders with Helicobacter pylori infection. B. Gawronska-Szklarz, J. Wrześniewska, T. Starzyńska, A. Pawlik, K. Safranow, K. Ferenc, M. Droździk. Eur J Clin Pharmacol 2005, 61, 375-379.
  17. Lack of association between arylamine N-acetyltransferase 2 (NAT2) polymorphism and systemic sclerosis. K. Skretkowicz, J. Skretkowicz, B. Gawrońska-Szklarz, W. Górnik, M. Rychlik-Sych, A. Sysa-Jedrzejowska. Eur J Clin Pharmacol. 2005, 60, 773-778.
  18. Effect of tibolone on turnover of cholesterol to bile acids in ovariectomized rats. Czerny B, Teister M, Juzyszyn Z, Mysliwiec Z, Pawlik A. Menopause. 2005;12:609-12.
Powrót
do góry